SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-245915
Filing Date
2017-08-02
Accepted
2017-08-02 16:54:57
Documents
6
Period of Report
2017-08-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d436251d8k.htm 8-K 51921
2 EX-3.1 d436251dex31.htm EX-3.1 6123
3 EX-3.2 d436251dex32.htm EX-3.2 4472
4 EX-10.1 d436251dex101.htm EX-10.1 37878
5 EX-16.1 d436251dex161.htm EX-16.1 1493
6 GRAPHIC g436251onco.jpg GRAPHIC 4718
  Complete submission text file 0001193125-17-245915.txt   110423
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 171000896
SIC: 2835 In Vitro & In Vivo Diagnostic Substances